Charles Schwab Investment Management Inc Oramed Pharmaceuticals Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $309,574 - $748,971	-83,219 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $143,423 - $243,241	17,512 Added 26.65%	83,219 $720,000
Q4 2021 Feb 11, 2022	BUY	$12.98 - $29.75 $18,898 - $43,316	1,456 Added 2.27%	65,707 $939,000
Q3 2021 Nov 16, 2021	BUY	$12.13 - $23.82 $92,297 - $181,246	7,609 Added 13.43%	64,251 $1.41 Million
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $472,394 - $826,406	56,642 New	56,642 $758,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.